Cialis (Tadalafil)

Generic Name

Tadalafil

Brand Names

Cialis, Adcirca, Opsynvi, Tadliq, ALYQ

FDA approval date: November 26, 2003

Classification: Phosphodiesterase 5 Inhibitor

Form: Tablet, Suspension

What is Cialis (Tadalafil)?

CIALIS ® is a phosphodiesterase 5 inhibitor indicated for the treatment of: erectile dysfunction .

Approved To Treat

Top Global Experts

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Related Clinical Trials

A Prospective, Open-label, Platform Study for Long-term Follow-up of Participants Using Study Intervention in Pulmonary Hypertension Parent Studies

Who is this study for: Patients with pulmonary hypertension

Enrollment Status: Recruiting

Publish Date: April 13, 2026

Intervention Type: Drug

Study Drugs: Macitentan, Selexipag, Tadalafil

Study Phase: Phase 3

Summary: The purpose of the study is to enable participants with pulmonary hypertension (PH) currently treated with study intervention(s) in a clinical study (parent studies \[NCT03422328, NCT03904693,NCT04565990, NCT02932410, NCT03492177, and NCT04175600\]), to continue to benefit from the intervention after closure of the parent study in case they have no alternative means of access to the study interven...

A Multicenter, Randomized, Double-Blind, Exploratory Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Enrollment Status: Recruiting

Publish Date: April 03, 2026

Intervention Type: Drug

Study Phase: Phase 4

Summary: This clinical trial will evaluate whether combination therapy with Dapagliflozin + Macitentan improves outcomes compared to Dapagliflozin + placebo in patients with combined pre- and post-capillary pulmonary hypertension (CpcPH). The study will measure changes in pulmonary vascular resistance, NT-proBNP, 6-minute walk distance, and quality of life (KCCQ scores) over 24 weeks. Participants will be ...

Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes

Enrollment Status: Recruiting

Publish Date: March 30, 2026

Intervention Type: Drug

Study Phase: Phase 4

Summary: investigate the effect of different vasodilators as Tadalafil in women with unexplained infertility using IVF

View All Clinical Trials